Perspective on Hepatitis C

As a hepatitis C virus (HCV) sufferer and a former health care worker, I would like to offer your readers some information from the perspective of a patient with HCV for more than 20 years. HIV has drawn all the attention, while 4-5 million people suffer from HCV. Why no help from the media? Once the liver is destroyed, our immune systems get compromised. The full effects of this virus are yet to be seen in our society. Methadone clinic patients are testing positive at an alarming rate for this

Written byKevin Donnelly
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

As a hepatitis C virus (HCV) sufferer and a former health care worker, I would like to offer your readers some information from the perspective of a patient with HCV for more than 20 years. HIV has drawn all the attention, while 4-5 million people suffer from HCV. Why no help from the media? Once the liver is destroyed, our immune systems get compromised. The full effects of this virus are yet to be seen in our society. Methadone clinic patients are testing positive at an alarming rate for this virus. Health care workers are not being properly monitored, and the Centers for Disease Control and Prevention only wants new cases reported to them, yet 80-90 percent of HCV sufferers are considered chronic.

Why are dentists, police, and fire departments, including paramedic rescue teams, not adequately educated about protecting themselves from this virus? What about the issues of liver transplants ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies